NeuroSense Therapeutics Ltd. Ordinary Shares (NRSN)
Stock · NASDAQ · Health Care
$0.4301as of 8/28/2026
Price chart
Open in TradingViewActive signals
High Beta31.9%
RSI Positive Divergence21.7%Resistance level
$0.710614
Industry
Biotechnology: Pharmaceutical Preparations
About NRSN
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from neurodegenerative diseases in the United States and internationally. The company's lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyot…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 17
- Website
- www.neurosense-tx.com/
Fundamentals
- 1-day range
- $0.25$0.5
- Market cap
- $19.00M
- P/E (trailing)
- —
- P/E (forward)
- -0.49
- EPS (trailing)
- $-0.62
- Dividend yield
- —
- Beta
- 1.56
- Avg. volume
- 254.0K
52-week range
$0.25$1.98
Forecasts
3 analyst ratings
Buy 89%
Hold 11%
Sell 0%
1-year price forecast
High
$9
+1992.5%
Median
$7.5
+1643.8%
Low
$3
+597.5%
NeuroSense Therapeutics Ltd. Ordinary Shares Competitors
Chosen by industry and closest market cap.
- NRSNNeuroSense Therapeutics Ltd. Ordinary Shares$0.4301▼ 2.03%Market cap $19.00MP/E —$0.25$1.98
- MRKRMarker Therapeutics Inc. Common Stock$1.37▼ 7.12%Market cap $18.67MP/E —$0.8099$2.46
- RKTORocket One Inc. Common Stock$0.7021▼ 2.76%Market cap $19.75MP/E —$0.691501$2.45
- GRDXGridAI Technologies Corp. Common Stock$4.05▲ 1.00%Market cap $19.91MP/E —$1.73$6.93
- DAREDare Bioscience Inc. Common Stock$0.7437▲ 0.64%Market cap $19.92MP/E —$0.73005$3.78
- NCELNewcelX Ltd. Ordinary Shares$3.19▼ 6.73%Market cap $17.98MP/E —$1.83$24.6
- LPCNLipocine Inc. Common Stock$2.2▼ 1.35%Market cap $17.56MP/E —$1.81$12.37
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| NRSN NeuroSense Therapeutics Ltd. Ordinary Shares | $19.00M | — | $0.4301 | ▼ 2.03% | $0.25$1.98 |
| MRKR Marker Therapeutics Inc. Common Stock | $18.67M | — | $1.37 | ▼ 7.12% | $0.8099$2.46 |
| RKTO Rocket One Inc. Common Stock | $19.75M | — | $0.7021 | ▼ 2.76% | $0.691501$2.45 |
| GRDX GridAI Technologies Corp. Common Stock | $19.91M | — | $4.05 | ▲ 1.00% | $1.73$6.93 |
| DARE Dare Bioscience Inc. Common Stock | $19.92M | — | $0.7437 | ▲ 0.64% | $0.73005$3.78 |
| NCEL NewcelX Ltd. Ordinary Shares | $17.98M | — | $3.19 | ▼ 6.73% | $1.83$24.6 |
| LPCN Lipocine Inc. Common Stock | $17.56M | — | $2.2 | ▼ 1.35% | $1.81$12.37 |
P/E shows — for peers not currently carrying a live signal of their own.
Insider Activity
Insider Actions →Acquired
600.0K
Disposed
0
- Eisenberg Or · March 26, 2026 · Grant200.0K
- Russek-Blum Niva · March 26, 2026 · Grant200.0K
- Binder Hagit · March 26, 2026 · Grant200.0K
See the full, filterable feed with live charts on the MarketWall dashboard.